Zeynep Aroglu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pembrolizumab led to a dramatic overall response rate among patients with unresectable desmoplastic melanoma.

United statesBristol myers squibbKari kendraZeynep arogluOhio state university wexner medical centerBoehringer ingelheimWashington university in stVarian medical systemsCheckmate pharmaceuticalsAmerican association for cancer researchAmerican associationBrian van tineWashington universityVarian medicalVan tineMalignant melanoma